key: cord-1004020-erkwrp61 authors: Huang, L.; Li, Y.; Luo, C.; Touil, N.; Annaz, H. e.; Cheng, Y.; Zeng, S.; Dang, T.; Liang, J.; Hu, W.; Xu, H.; Tu, J.; Shen, Y.; Liu, G. L. title: One-Step Rapid Quantification of Serum Neutralizing Antibody after COVID-19 Vaccination by a High-Throughput Nanoplasmonic Sensor Platform date: 2021-04-27 journal: nan DOI: 10.1101/2021.04.21.21255838 sha: 99405ebd1c5f16f88be9e58691d16b99e7f47d44 doc_id: 1004020 cord_uid: erkwrp61 The COVID-19 vaccination efficacy depends on serum production level of the neutralizing IgG antibody (NA) specific to the receptor binding domain of SARS-Cov-2 spike protein. Therefore, a high-throughput rapid assay to measure the total SARS-CoV-2 NA level is urgently needed for COVID-19 serodiagnosis, convalescent plasma therapy, vaccine development, and assessment. Here, we developed a nanoplasmonic immunosorbent assay (NanoPISA) platform for one-step rapid quantification of SARS-CoV-2 NAs in clinical serum samples for high-throughput evaluation of COVID-19 vaccine effectiveness. The NanoPISA platform enhanced by the use of nanoporous hollow gold nanoparticle coupling was able to detect SARS-CoV-2 NAs with a limit of detection of 0.1 ng/mL within 15 min. The one-step NanoPISA for SARS-CoV-2 NA detection in clinical specimens yielded good results, comparable to those obtained in the gold standard seroneutralization test and the surrogate virus neutralizing ELISA. Collectively, our findings indicate that the one-step NanoPISA may offer a rapid and high-throughput NA quantification platform for evaluating the effectiveness of COVID-19 vaccines. conducive for biomedical applications. [32] [33] [34] Therefore, we hypothesized that a combination of nanoplasmonic nanocup sensor and NHGNPs might deliver a stronger SPR effect, which, in turn, would enable higher detection sensitivity. To validate this hypothesis, we developed a high-throughput nanoplasmonic sensor platform for one-step rapid quantification of COVID-19 antibodies to evaluate the large-scale vaccine effectiveness (Schematic 1). The low-cost nanoplasmonic sensor platform uses an antigen sandwich method, in which the antigen S-RBD protein is used to detect total SARS-CoV-2 NAs produced by the human body. The NanoPISA can achieve high throughput detection without signal amplification and washing procedures within 15 min. The NHGNP-coupled NanoPISA platform was able to detect SARS-CoV-2 NAs in serum with an enhanced sensitivity and the limit of detection (LOD) of 0.1 ng/mL. In addition to their superior stability in serum, the NHGNPs have much larger surface area and stronger plasmon resonance than conventional colloidal GNPs, so they support higher protein density and larger resonance coupling when binding to antibodies and then to the nanoplasmonic device surface. The detection results of our developed sensor strongly correlated with those achieved by the standard ELISA (R 2 = 0.995). Moreover, the performance of the sensor in the clinical setting was further validated by testing clinical serum specimens from 139 people that received vaccination in two nations -China and Morocco. The NanoPISA results were compared with the result of both the seroneutralization (SN) test and the surrogate virus neutralizing ELISA results. The NanoPISA exhibited over 96% sensitivity and 90% specificity. Therefore, we believe that the ultrasensitive SARS-CoV-2 detection of NAs by using NanoPISA will be very useful for the evaluation of the large-scale vaccine effectiveness and prevention of COVID-19 and other mass infectious diseases. Scheme 1. One-step rapid quantification of the total SARS-CoV-2 NAs with the NHGNPenhanced coupled NanoPISA platform. Characterization of the nanoplasmonic sensor chip and NHGNPs. In this study, the periodic nanocup array sensor chip was fabricated on a polymer substrate with a diameter of 200 nm, depth of 500 nm, and periodicity of 400 nm, in which titanium (Ti) and silver (Ag) layers were 9 nm and 70 nm in thickness, respectively. It can be clearly observed that the nanocup array All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.21.21255838 doi: medRxiv preprint exhibited high uniformity in the scanning electron microscope image ( Figure 1A ). The sensor chip surface had distinct colors in the media with different refractive indices (RIs), such as air (RI = 1.0) and water (RI = 1.3), which shows that the sensor chip has superior detection sensitivity ( Figure 1A ). The NHGNP particle size was 107.2 nm with the polydispersity Index of 0.163 ( Figure 1B ). The synthesized NHGNPs had a negative charge (−42.48 mV) on the surface, which maintained quite a stable state because of the electrostatic repulsion caused by the adsorption of citrate ions ( Figure S1 ). Transmission electron microscopy (TEM) images revealed that the morphology of the typical NHGNP was polyporous and hollow ( Figure 1B) . Moreover, the solution of NHGNPs had an effective absorption peak around 620 nm to match better the resonance peak of the nanoplasmonic sensor chip ( Figure S2 ). Many studies have reported that a significant improvement in SPR performance could be achieved by coupling GNPs to the nanoplasmonic nanocup arrays, which was attempted for the generation of denser hot spots when the plasmonic GNPs were assembled on the surface of nanocups. 27, [35] [36] GNPs in the range of 20-40 nm in diameter were generally recommended for use in biological detection procedures due to their sufficient stability and immune reactivity. [37] [38] [39] However, only large GNPs that fit in the nanocup size can effectively help to increase the intensity of the localized electric field and improve the detection sensitivity. [40] [41] Thus, NHGNPs with higher stability and larger diameter (~100 nm) will be a potential strategy to improve the SPR effect on the nanocup sensor chip. A quick verification of the above idea was demonstrated using the FDTD method. As expected, a stronger electric field and absorption spectra was confined in the inner cavity of the nanocup, All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. when the NHGNPs were assembled on the nanocup array compared to colloidal GNPs ( Figure 1F -H, Figure S3 ). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. NHGNPs have peculiar plasmonic properties and a large exposed surface area, which attracted great scientific interest in the field of chemical and biological detection sensors. 42 The maximization of the sensor sensitivity is achieved by the extraordinarily high structural stability of ultrafine NHGNPs. In this system, we utilized GNP-based nanoplasmonic sensor chips to quantify NAs to SARS-CoV-2. The highly specific S-RBD, which is a key target of host NAs and an important factor in vaccine design, can be used to detect total NAs in human serum. The detection schematics is illustrated in Figure 2 , the mouse anti-human IgG solution was coated on a low-cost ultrasensitive biosensor integrated into the standard 96-well plate. When serum positive for SARS-CoV-2 NAs and the GNP-labeled S-RBD protein reagent are added successively, the target SARS-CoV-2 NAs in the serum will initially specifically bind to the GNP-labeled S-RBD and then will be captured by the anti-human IgG on the 96-well chip All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.21.21255838 doi: medRxiv preprint surface, forming the sandwich immune conjugate particles of protein-antibody-antibody. As a result, the immune conjugate particles will generate SPR effect via the ultrasensitive plasmonic biosensor chip and change optical density (OD) at a specific wavelength in the microplate reader. The relative OD value is proportional to the SARS-CoV-2 NAs concentration in serum. In addition, the NHGNP-enhanced coupled resonance nanoplasmonic sensor detection platform enables to improve the sensitivity and shorten the detection time to 15 min. The developed GNP-enhanced NanoPISA biosensor was able quantitatively detect SARS-CoV-2 NAs based on the GNP-labeled S-RBD protein ( Figure 2A ). The NanoPISA was effective for rapid and high-throughput (96-wells) antibody testing due to its much shorter detection time NAs. The real-time dynamic binding curves of the sandwich immune conjugate particles interaction at resonant wavelength 610 nm are shown in Figure 2C . The relative OD intensity All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 27, 2021. positively correlated with SARS-CoV-2 NAs concentration, whereas the dynamic curve of the control blank group showed almost no change. Furthermore, the difference between the relative OD change at 610 nm and 590 nm was obtained from the differential absorption spectra at 15 min. The standard curve of the relative OD value in the colloidal GNP-enhanced NanoPISA relative to the concentration of SARS-CoV-2 NAs in the range from 0 to 640 ng/mL is shown in Figure 2C . The standard curve is a sigmoid curve obtained using a four-parameter logistic model, and the correlation coefficient (R 2 ) was 0.992. The LOD of the colloidal GNP-enhanced NanoPISA for the SARS-CoV-2 NA detection was estimated to be 5 ng/mL. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. NHGNP-enhanced NanoPISA for quantitative determination of SARS-CoV-2 NAs. The excellent colloidal stability of GNPs is very important for their various applications in different fields of sciences. Unfortunately, the stability of colloidal GNPs can be easily affected by many external factors, such as solution environment and protein concentration. [43] [44] However, NHGNPs with stronger SPR properties, larger surface area, and higher stability in aqueous solutions may have higher detection sensitivity than colloidal GNPs. Based on the nanoplasmonic sensor chip plate, we developed an enhanced detection reagent with high stability of NHGNPs that enabled over 50-fold increase in the detection sensitivity ( Figure 3A) . Similarly, the anti-human IgGmodified sensor surface and nanoporous hollow AuNP-labeled S-RBD protein were used for rapid detection of SARS-CoV-2 NAs by one-step method as described above. In the typical differential absorption spectra of the NHGNP-enhanced sensor chip, the specific resonant wavelengths appeared at 590 nm and 650 nm ( Figure 3B ). The opposite variation values, proportional to the different concentrations of SARS-CoV-2 NAs, were also observed at 590 nm and 650 nm at 15 min. In addition, the dynamic curves of SARS-CoV-2 NAs at different concentrations and the blank control sample showed obvious distinction within 5 min ( Figure 3C ). As expected, the one-step NHGNP-enhanced NanoPISA significantly improved the detection sensitivity of SARS-CoV-2 NAs at a concentration of 0.1 ng/mL, which was 50 times more sensitive than colloidal GNP-enhanced NanoPISA. Furthermore, the standard curve of the difference between the relative OD values at 650 nm and 590 nm with respect to different All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. concentrations of SARS-CoV-2 NAs was obtained from the differential spectra, and the 4parameter logistic curve fitting. The R 2 was found to be 0.998 over the range of SARS-CoV-2 NA concentrations from 0.5 to 125 ng/mL ( Figure 3D ). At present, a safe and effective COVID-19 vaccine is the best way to control and ultimately end the pandemic, so the development of COVID-19 vaccines is moving at unprecedented speeds. However, the question of how to evaluate the effectiveness of the vaccine is very challenging. In this study, the proposed one-step NanoPISA platform not only detected SARS-CoV-2 NAs with ultrahigh sensitivity and effectiveness, but also significantly relieved the workload of medical personnel who analyzed numerous serum samples from vaccinated people, consequently improving the efficiency of the evaluation of vaccine effectiveness. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure S4 . SARS-CoV-2 antibodies were diluted in a buffer to obtain a concentration range of 10-640 ng/mL (the same concentration range applied for ELISA). The resulting sensor calibration curve is displayed in Figure S5 . Each data point was averaged from two independent measurements. Figure S6 shows the corresponding SARS-CoV-2 antibody standard curve measured by ELISA. A very good correlation between NanoPISA and ELISA was achieved for the detection of SARS-CoV-2 antibody dissolved in the buffer and the fitting R 2 was 0.995 ( Figure S7 ). To determine the accuracy of the proposed AuNP-enhanced NanoPISA for SARS-CoV-2 antibody detection, we analyzed three samples of SARS-CoV-2 antibody in buffer with different concentrations from 20 ng/mL to 160 ng/mL using NanoPISA and ELISA. The average value and accuracy rate for each sample were calculated. As shown in Table S1 , the accuracy rate in the same sample is between 80% and 120%, indicating that both the NanoPISA and ELISA have good stability and accuracy. The NanoPISA was optimized to use relatively small sample volumes (∼50  L) while maintaining high sensitivity in comparison with ELISA, which can be attributed to the use All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. AuNP-enhanced coupled resonance nanoplasmonic sensor chip. Another major advantage of the NanoPISA technique is that SARS-CoV-2 antibody can be quickly detected with higher throughput compared with ELISA. The high throughput and detection speed of the NanoPISA allowed for all sample tests to be finished within 15 min, whereas it took over 3 h to complete the conventional ELISA. (Table 1 ) as well as the SN test (Table 2) . NanoPISA results of the 139 clinical serum samples were first compared with the results of the surrogate virus neutralizing ELISA. The percentage of NanoPISA NA-positive samples was similar to that seen with ELISA. NanoPISA exhibited 95.7% sensitivity and 89.1% specificity compared to those of ELISA (Table 1 ). In addition, the χ 2 test was used to compare the results between NanoPISA and ELISA, which showed that the P-value of the McNemar test was 1.0, and the value obtained with the kappa test was 0.898 (P < 0.001). The results of the NanoPISA were not significantly different from those of ELISA. In addition, SARS-CoV-2 NA levels in 68 clinical serum samples also showed very strong concordance between the NanoPISA and SN test All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04. 21.21255838 doi: medRxiv preprint In this study, we have described a rapid and high throughput nanoplasmonic sensor-based assay, or NanoPISA, for SARS-CoV-2 NAs. A 96-well biosensor chip plate device was pre-coated with mouse anti-human IgG and with NHGNP-labelled S-RBD , the samples were subsequently added for directly measuring SARS-CoV-2 NA levels in blood serum. The unique nanoplasmonic mechanism through NHGNPs coupled to the nanocup sensors enable highly sensitive and rapid SARS-CoV-2 NAs detection in one step. When diagnosing the clinical serum samples, there was very strong concordance between the results of the NanoPISA for SARS-CoV-2 NAs and those of the conventional ELISA and SN assay. In addition, compared with the conventional ELISA and SN assay, the NanoPISA shortened the total detection time from days and hours to within only 15 min and improved the testing capacity to simultaneous high throughput detection of up to 96 samples. We therefore conclude that the NanoPISA (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Surface functionalization. Chip surface modification was prepared as described in our previous study. 19 In brief, 100 μL of 50 mM sulfhydryl succinic acid solution was added into a homemade 96-well chip plate and kept for 1 h at room temperature. After cleaning the chip well with deionized water twice, 100 μL of 400 mM EDC and 100 mM NHS (in PBS) was added and All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.21.21255838 doi: medRxiv preprint left for 30 min to activate the carboxyl group of sulfhydryl succinic acid at room temperature. Next, the chip wells were rinsed with deionized water and 50 μL of an 8.0 μg/mL anti-human IgG PBS solution was immediately immobilized on the activated chip wells for 4 h at room temperature. Then, the chip wells were blocked with 100 μL of a 60 μg/mL BSA solution and then with 100 μL of a 10% ethanolamine solution for 30 min at room temperature, respectively. Finally, the functionalized chips were gently rinsed with deionized water twice and stored at 4°C for further use. Colloidal GNPs were prepared by a sodium citrate reduction method. [45] [46] Briefly, 300 mL of 1 mM of HAuCl4 was heated until it boiled and then 15 mL of 75 mM citrate was added to the boiling solution. A dark red color solution was obtained, which was boiled continuously for another 15 min and then allowed to cool down to room temperature. The typical procedure of labeling the S-RBD protein with colloidal GNPs was employed as described in our previous work. 29 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The morphology and size of the synthesized NHGNPs based on Co templates were characterized by transmission electron microscopy (TEM, HT7700, Japan) with a CCD camera operating at an accelerating voltage of 100 kV. The NHGNP particle size distribution was determined by dynamic light scattering on a Zetasizer Nano-ZS90 analyzer (Malvern Instruments, UK). The absorption spectra of NHGNPs ranging from 400 to 900 nm were obtained using a UV-vis spectrophotometer (Agilent 8453, USA) at 25°C. S-RBD protein labeling with NHGNPs was done as described in our previous work , with minor modifications as follows. 29 Briefly, 9 L of a 0.93 mg/mL S-RBD protein solution in PBS was added to a 0.2 mg/mL NHGNP solution and incubated with NHGNPs for 15 min. Then, 15 μL of the blocking solution containing PEG 2W (10%, w/v) was added into the NHGNP solution and incubated for 15 min. Then, the NHGNP suspension was centrifuged at 7,500 rpm for 20 min. Finally, the NHGNP precipitate was resuspended in 530 μL of the stabilizing buffer (20 mM Tris, pH 9.2, 0.3% sucrose, 0.05% PEG 20000) and stored at 4°C for further experiments. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The typical original spectra and dynamic interaction kinetics of the SARS-CoV-2 NAs were recorded using a generic microplate reader at the specific resonant wavelength. After 15 min, the final spectra of solutions with different concentrations of NAs were recorded again by using a generic microplate reader. Detection of SARS-CoV-2 NAs in human serum samples was the same as in the protocol described above, but for the sample preparation step, the plasma or serum samples required 1:100 dilution with sample diluent buffer (10 mM PBS, 1% BSA) to fall within the range of the assay. Plasma samples were obtained by centrifuging blood samples at 2,500×g and 4°C for 15 min. The serum samples were stored at −80°C. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In addition, the detection of the SARS-CoV-2 NAs by NanoPISA were validated by SARS-CoV-2 Antibody Assay ELISA kit (XG100H2, AbMax Biotechnology Co., Ltd.) and SARS-CoV-2 surrogate virus neutralizion ELISA kit (L00847-A, Nanjing GenScript Biotech Co., Ltd.). The Supporting Information is available free of charge on the ACS Publications website. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 27, 2021. ; Figures of potential, absorption spectra of NHGNPs, the FDTD simulated absorption spectra of Yan Shen: Supervision, Funding acquisition, Project administration. Gang L. Liu: Supervision, Writing -review & editing Nanotechnology for COVID-19: Therapeutics and Vaccine Research Saliva-based molecular testing for SARS-CoV-2 that bypasses RNA extraction A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation Diagnosing COVID-19: The Disease and Tools for Detection Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor Rapid, Ultrasensitive, and Quantitative Detection of SARS-CoV-2 Using Antisense Oligonucleotides Directed Electrochemical Biosensor Chip Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor Distinct viral clades of SARS-CoV-2: Implications for modeling of viral spread The spike protein of SARS-CoV -a target for vaccine and therapeutic development Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor SARS-CoV-2 vaccines in development Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes. Vaccines (Basel) 2020 Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma ELISA detection of SARS-CoV-2 antibodies in saliva Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG SARS-CoV-2 infection serology: a useful tool to overcome lockdown? Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay Multiplexed nanoplasmonic biosensor for one-step simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine C-Reaction Protein Detection in Human Saliva by Nanoplasmonic Color Imaging Photonic crystal and plasmonic nanohole based label-free biodetection Nanoparticle-Enhanced Plasmonic Biosensor for Digital Biomarker Detection in a Microarray Rapid and Digital Detection of Inflammatory Biomarkers Enabled by a Novel Portable Nanoplasmonic Imager Onestep rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device Cancer Theranostics with Near-Infrared Light-Activatable Multimodal Nanoparticles Cisplatin-loaded hollow gold nanoparticles for lasertriggered release The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy A sensitive SPR biosensor based on hollow gold nanospheres and improved sandwich assay with PDA-Ag@Fe3O4/rGO Magnetic field-assisted SPR biosensor based on carboxyl-functionalized graphene oxide sensing film and Fe3O4-hollow gold nanohybrids probe Sensitivity Tuning through Additive Heterogeneous Plasmon Coupling between 3D Assembled Plasmonic Nanoparticle and Nanocup Arrays Development and evaluation of a gold nanoparticle-based immunochromatographic strip test for the detection of canine parvovirus Factors influencing the detection limit of the lateral-flow sandwich immunoassay: a case study with potato virus X Lateral Flow Technology for Field-Based Applications-Basics and Advanced Developments Strong Enhancement of the Radiative Decay Rate of Emitters by Single Plasmonic Nanoantennas Plasmonic Nanogap-Enhanced Raman Scattering Using a Resonant Nanodome Array Novel Nanoporous Au − Pd Alloy with High Catalytic Activity and Excellent Electrochemical Stability Rapid detection of aflatoxin B1 on membrane by dot-immunogold filtration assay Schiff base and Lewis acidbase interaction-regulated aggregation/dispersion of gold nanoparticles for colorimetric recognition of rare-earth Sc3+ ions Synthesis and spectroscopic characterization of gold nanoparticles The preparation of gold nanoparticles and evaluation of their immunological function effects on rats The authors declare no competing financial interest. We would like to thank Editage (www.editage.cn) for English language editing. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.